Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Lidocaine for Postoperative Pain in Gynaecological Surgery
NCT03363425Phase 3Unknown
- Sponsor
- National and Kapodistrian University of Athens
- Start
- Nov 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Lidocaine, Dexmedetomidine and Placebo (3 arms). Primary endpoint: Analgesic Consumption 24 Hours Postop. Status: unknown.
02
Drugs
dexmedetomidineLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03363425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03363425.